4th of July Sale: Create a Free Seeking Alpha Account
Our 20% off sale is extended to 4th of July! Markets change, but our community always has the latest news, in-depth analysis, and powerful stock ratings.

or
By creating an account using any of the options above, you agree to the Terms of Use & Privacy Policy

NBIO Nascent Biotech, Inc.
Stock Price & Overview

$0.0003-0.0001 (-25.00%)9:58 AM 07/03/25
OTCQB | $USD | Delayed

NBIO Stock Price

EPS
PE
Div Rate
Yield
Short Interest
Market Cap
Volume
Prev. Close
Expand For Key Data »

Quant Ranking

NBIO Analysis

NBIO News

Latest Headlines

People Also Follow

Similar to NBIO

ETFs Holding NBIO

NBIO Company Profile

Nascent Biotech, Inc. logo
Nascent Biotech, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of various forms of cancer. It is developing Pritumumab, a drug to treat patients with brain cancer malignancies, such as glioblastoma and malignant astrocytoma, as well as epithelial cancers, including lung, breast, colon, brain, and pancreas cancer. The company is developing MultiPharm, a proprietary technology platform for cancer therapy, as well as diabetes, autoimmunity, and transplantation. In addition, it develops CLNH5. Nascent Biotech, Inc. is based in North Palm Beach, Florida.
Sector
-
Industry
-
Employees
-
Founded
-
Address
  • 631 US Hwy 1
  • Suite 407
  • North Palm Beach, FL, 33408
  • United States
Phone Number
612 961 5656
Website
www.nascentbiotech.com
Hide

NBIO Revenue

More On Revenue »

NBIO Earnings Per Share

More On Earnings »

Earnings Revisions

Profitability

Momentum

Capital Structure

Dividends

NBIO does not currently pay a dividend.

NBIO Ownership

NBIO Peers

Risk

Technicals

NBIO SEC Filings

See All SEC Filings »

Press Releases

NBIO Income Statement

NBIO Balance Sheet

NBIO Cash Flow Statement

NBIO Long Term Solvency

Nascent Biotech, Inc. (NBIO) Frequently Asked Questions